STEPHEN DAVIS - 15 Jun 2022 Form 4 Insider Report for BELLICUM PHARMACEUTICALS, INC

Role
Director
Signature
/s/ Richard A. Fair, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
15 Jun 2022
Net transactions value
$0
Form type
4
Filing time
16 Jun 2022, 14:49:04 UTC
Previous filing
03 May 2022
Next filing
02 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLCM Stock Option (right to buy) Award $0 +15,000 $0.000000 15,000 15 Jun 2022 Common Stock 15,000 $1.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest and become exercisable in full on the one-year anniversary of the grant date.